Taxonomic intestinal microbiota differences in Lewy body spectrum disease and cohabitant controls
Parkinsonism & Related Disorders 129: 107176-107176
Article 2024 English
Authors
LT
Levi Teigen
SM
Stuart J. McCarter
ZZ
Zachary Ziegert
Abstract
1 min read
Background
Microbial dysbiosis has been reported to contribute to development of neurodegenerative diseases, however, there is a need to identify causative/prognostic indicators.
Objectives
To comparatively analyze gut microbiome composition in symptomatic LBD (dementia/mild cognitive impairment), iRBD, and cohabiting controls without LBD or iRBD.
Methods
16S rRNA amplicon sequencing was performed in 38 cases (27 LBD, 11 iRBD) and 39 cohabitant controls. 19 non-cohabitant healthy controls (HCs) were also included to contrast differences between cohabitant cases and controls.
Results
Microbiome composition of cohabitant controls and LBD and iRBD cases were strikingly similar. No differences were observed between LBD, and iRBD only showed reduced Bacteroides, compared with cohabitant controls. There were several taxonomic differences in gut microbiome composition between non-cohabitant HCs and cases.
Conclusions
Minimal microbiome differences were observed between iRBD or LBD cases and cohabitant controls. These findings underscore the importance of using cohabiting controls in future gut microbiome studies.
Anastasiya Slyepchenko, Michael Maes, Felice N. Jacka, Cristiano A. Köhler, Tatiana Barichello, Roger S. McIntyre, Michael Berk, Iría Grande, Jane A. Foster, Eduard Vieta, André F. Carvalho
Enrique Zozaya‐Valdés, Stephen Q. Wong, Jeanette Raleigh, Athena Hatzimihalis, Sarah Ftouni, Anthony T. Papenfuss, Shahneen Sandhu, Mark A. Dawson, Sarah‐Jane Dawson
Bo Su, Haihua Liu, Xinglong Wang, Shu G. Chen, Sandra L. Siedlak, Eisei Kondo, Raymond Choi, Atsushi Takeda, Rudy J. Castellani, George Perry, Mark A. Smith, Xiongwei Zhu, Hyoung‐gon Lee
Discussion(0)
No comments yet. Be the first to comment.